In electrophysiological measurements, the presence of a diffusion potential disturbs the precise measurement of the reverse potential by altering the electrode potential. Using a micro-agar salt bridge, the impact of the diffusion potential is minimized, which allows a more precise measurement of substrate turnover numbers of reconstituted recombinant membrane proteins.
To date, more than 50% of all pharmacological drugs target the transport kinetics of membrane proteins. The electrophysiological characterization of membrane carrier proteins reconstituted in lipid bilayer membranes is a powerful but delicate method for the assessment of their physicochemical and pharmacological properties. The substrate turnover number is a unique parameter that allows the comparison of the activity of different membrane proteins. In an electrogenic transport, the gradient of the translocated substrate creates a membrane potential that directly correlates to the substrate turnover rate of the protein. By using silver chloride electrodes, a diffusion potential, also called liquid junction potential, is induced, which alters electrode potential and significantly disturbs precise membrane potential measurements. Diffusion potential can be minimized by a salt bridge, which balances electrode potential. In this article, a micro-agar salt bridge is designed to improve the electrophysiological set-up, which uses micropipettes for the membrane formation. The salt solution is filled into a microcapillary pipette tip, stabilized by the addition of agarose, and can be easily mounted to a standard electrode. The electrode potential of a micro-salt bridge electrode is more stable compared to a standard electrode. The implementation of this system stabilizes electrode potential and allows more precise measurements of membrane potential generated by a pH gradient. Using this system, the proton turnover rates of the mitochondrial carriers UCP1 and UCP3 are reinvestigated and compared to earlier measurements.
Membrane proteins are targeted by up to 60% of all known pharmaceutical drugs1. Electrophysiological measurements of membrane proteins are a powerful but delicate tool to analyze the electrogenic transport of substrates mediated by membrane carrier proteins. The modulation of the transmembrane current by the application of constant voltages or voltage ramps allows assessing the pharmacological and physical properties of the carriers, for instance, the activation and inhibition by substrates or the transport kinetics. Of special interest is the substrate turnover number, which displays the amount of substrate that is translocated by a membrane protein per time unit. It is a major parameter when comparing the kinetics of various membrane proteins. Establishing a concentration gradient of the charged substrate across the membrane generates an electromotive force from which the turnover number of the substrate is deduced.
Using an AgCl electrode, the presence of a chloride-free buffer creates a diffusion potential that alters electrode potential and leads to a shift in current-voltage measurements2. Although always present, it is negligible for standard conductance and capacity measurements since these parameters are either dependent on the slope of the current-voltage recording (conductance) or are the difference of a single recording (capacity), which cancels the potential. However, the recording of the reverse potential, which is created by the transport of substrate, can be significantly disturbed by the diffusion potential. Thus, for exact measurements of the reverse potential, the electrode potentials have to be kept constant.
The diffusion potential can be minimized by two methods: (i) in the presence of a bilayer membrane, a substrate concentration has to be increased on one side of the membrane3,4, or (ii) a salt bridge balances the electrode potential5. The first method is highly dependent on the stability of the measurements. The membrane has to survive for several minutes, from the addition of substrate under stirring until the substrate is almost equally distributed in the solution. If the membrane ruptures in between, the substrate gradient is altered by the free exchange of charged molecules, and measurements turn inaccurate. The latter method balances the diffusion potential but is limited by the size of the set-up. Implementing a small but functioning salt bridge in a micro range to an electrophysiological set-up is challenging6. For the latter method, the salt solution is filled into a microcapillary tip and stabilized by the addition of agarose to prevent diffusion of the salt solution to the buffer solution.
In this protocol, a straightforward production of a micro-agar salt bridge and implementation into an electrophysiological set-up based on the pipette set-up7 is described. A microcapillary tip is adjusted both to contain a 3 M KCl solution with 1 mol% (w/v) agarose and to bridge an AgCl electrode and buffer solution. The advantage of the micro-salt bridge is displayed by time recordings of the electrode potential shift and the more precise measurements of membrane potential at various pH gradients. In the model system of recombinant proteins reconstituted into liposomes, the turnover rates of mitochondrial carriers UCP1 and UCP3 produced under similar conditions are reinvestigated and compared to previous results3,8.
1. Production of Recombinant Uncoupling Proteins (UCPs) and the Formation of Planar Bilayer Membranes
2. Preparation of the Micro-agar Salt Bridge Electrode
3. Measurement of the Electrical Parameters of the Membrane Reconstituted with Recombinant Protein
4. Calculation of the Substrate Turnover Rate
NOTE: See previous work for details3,7.
To verify the minimization of the diffusion potential, the stability of the current-voltage measurements of an intact membrane was measured. In Figure 2A, representative-current voltage recordings are depicted in the presence (white dots) and absence (black dots) of a pH gradient. According to the Nernst equation, the pH gradient induces a shift in voltage. From the x-axis intersection point of a linear fit to the data, the potential shift is calculated. In order to test both electrodes, the shift in x-axis intersection point was analyzed for a standard AgCl electrode (Figure 2B; white dots) and a micro-agar salt bridge (Figure 2B; black dots). A voltage ramp was recorded ten times in a row and the mean shift in the x-axis is depicted against time. Whereas the agar salt bridge electrode had a maximum shift of less than 5 mV even after 300 seconds of measurement, the standard electrode varied up to 30 mV in unpredictable, random, behavior.
Next, both electrodes were tested at different pH gradients (Figure 3A). For the standard electrode, a pH gradient of 0.35 and 1.0 (white dots) was generated; for the agar salt bridge electrode, pH gradients of 0.35, 0.7, and 1.0 (black dots). The shift in potential was analyzed in three independent measurements. In contrast to a gradient of 0.35, where the measured shift only varies slightly, the voltage shift significantly alters at the pH gradient of 1.0 in the absence of the micro-agar salt bridge. From a linear fit to the data, the slope of the function is 26.4 ± 2.3 mV/ΔpH for the standard electrode and 50.1 ± 4.6 mV/ΔpH for the micro-agar salt bridge electrode. According to the Nernst equation, the calculated potential shift is 60.7 mV/ΔpH at T = 32 °C.
Using the micro-agar salt bridge, the proton turnover number, κ, of mitochondrial UCP1 and UCP3 was measured and compared to previous measurements (Figure 3B). Similar to Figure 3A, ΔpH = 1.0 was generated and the reverse potential was measured. The amount of protein in the membrane was estimated according to the formula provided in section 4 of the protocol, with a protein to lipid ratio of 4 µg/(mg of lipid), a molecular mass of 33,000, and 750 Da for the protein and lipid, a membrane surface area of 3.53 x 10-4 cm2, and an area per lipid of 7.8 x 10-15 cm2. The obtained κwas 5.56 ± 0.38 s-1 and 4.10 ± 0.71 s-1 for UCP1 and UCP3, respectively (Figure 3B).
Figure 1: The electrophysiological set-up with the micro-agar salt bridge. (A) This panel shows a sketch of the set-up. The microcapillary tip containing the agar salt solution (depicted in orange) is placed between the electrode (black) and the buffer-containing tip (blue). The membrane is formed at the surface at the end of the buffer-containing tip (indicated by the arrow). (B) This panel shows an image of the electrophysiological set-up with the implementation of the micro-agar salt bridge. The arrows point to the electrode, the micro-agar salt bridge, the reference electrode, and the container with buffer solution. Please click here to view a larger version of this figure.
Figure 2: The comparison of a micro-agar salt bridge and a standard AgCl electrode. (A) This panel shows a representative current-voltage measurement in the presence (grey dots) and absence (white dots) of a pH gradient of 1. The lines represent a linear fit to the data, from which conductance and x-axis intersection values are obtained. The voltage shift is evaluated by the difference of the intersection values of both recordings. (B) This panel shows the shift of membrane potential of a standard AgCl electrode (white dots) to a micro-agar salt bridge electrode (black dots) in time. Ten current-voltage measurements were recorded in a row and the mean voltage shift by diffusion potential is plotted against time. In all experiments, the membrane was made of 45:45:10 mol% DOPC:DOPE:CL reconstituted with 15 mol% arachidonic acid at a concentration of 1.5 mg/mL. The buffer contained 50 mM Na2SO4, 10 mM MES, 10 mM TRIS, and 0.6 mM EGTA at pH = 7.34 and T = 32 °C. Please click here to view a larger version of this figure.
Figure 3: Proton turnover number of UCP1 and UCP3 calculated from the reverse potential in the presence of a pH gradient. (A) This panel shows the shift in potential of a UCP1-containing membrane of various pH gradients of a standard AgCl electrode (white dots) and a micro-agar salt bridge electrode (black dots). The lines represent a linear fit to the data. (B) This panel shows the proton turnover number of UCP1 (first data set) and UCP3 (second data set) as calculated from the ratio of voltage shift to Nernst potential according to the formulas in section 4 of the protocol. The first bar of each set represents turnover rates measured with the micro-agar salt bridge. The second bar of each data set represents previous measurements using a standard AgCl electrode. Values for UCP1 and UCP3 were taken from Urbankovaet al.3 and Macher et al.8. In all measurements, the membrane was made of 45:45:10 mol% DOPC:DOPE:CL reconstituted with 15 mol% AA and UCP1/UCP3. The concentration of lipid and protein was 1.5 mg/mL and 4 µg/mg of lipid, respectively. The buffer contained 50 mM Na2SO4, 10 mM MES, 10 mM TRIS, and 0.6 mM EGTA at pH = 7.34 and T = 32 °C. The pH of the buffer for the gradient measurements was increased to 7.66, 8.00, or 8.33 by adding TRIS and was changed in the solution-containing pipette. The values are the mean ± standard deviation of three independent measurements. Please click here to view a larger version of this figure.
The implementation of the micro-agar salt bridge with the electrode minimizes its diffusion potential and allows more precise measurements of membrane potential generated by a pH gradient. In the presence of various transmembrane pH gradients, the potential shift of both electrodes was acceptable at ΔpH = 0.35 when comparing to the theoretical value of the Nernst equilibrium potential (ΦNernst =23.8 mV for ΔpH = 0.4). However, at more physiological pH gradients, as for instance in mitochondria between the matrix and intermembrane space, the standard AgCl electrode failed to precisely measure the potential shift at ΔpH = 1 (Figure 3A). The electrode bridged with micro-agar salt delivered the values which were much more comparable to the theory.
Diffusion potential may also occur at the AgCl reference electrode if the buffer solution is changed during the experiment. Chloride-free buffer solution was used in the experiments since uncoupling proteins were suggested to transport chloride ions, and the pH was adjusted using Tris or MES. The electrode potential, in the absence of a substantial concentration of chloride, primarily depends on chloride impurities in the buffer solution. As its composition is unchanged during the experiments, it will simply result in a constant offset potential. However, for the measurement of an absolute potential difference between the two electrodes, a simple agar salt-bridge system (Ag/AgCl 3 M KCl) could also be used for the reference electrode.
A micro-agar salt bridge balances the diffusion potential by an equilibration of the electrode potential. In order to stabilize the salt solution, 1% (w/v) agarose was added to prevent the mixing of the salt solution with the buffer solution. The salt ions K+ and Cl– have similar mobilities in liquid and balance the electrode potential. To properly install the salt bridge, the agar salt solution has to be sufficiently heated up to fill the microcapillary tip without any air bubbles and to cover the AgCl electrode. Before further usage, electrical contact between the salt bridge electrode and the reference electrode has to be checked. Depending on the time the salt bridge is used, the salt solution has to be sufficiently gelled to prevent any mixing of the salt solution with the buffer. This is especially critical if K+ or Cl– transporters are investigated. The salt bridge was used for a very short time and the elution of agarose is negligible in this time range. A higher concentration of agarose of up to 5%, or of agar (3% – 5%), allows using the salt bridge for a longer period of time6,12.
This method allows determining the transport kinetics of a membrane transporter (i) with low turnover rates and (ii) of mitochondrial proteins of the inner membrane, which can hardly be investigated in standard patch clamp set-ups13. Its precision is mainly dependent on the reverse potential measurement, which accuracy is decreased at a low total membrane conductance and small concentration gradients which induce a membrane potential below the noise of recording.
Using this set-up, the turnover rates of UCP1 and UCP3 as produced under the same conditions were measured. Due to the higher pH gradient, the obtained rates seem to be more precise and unperturbed by artefacts resulting from the minor electrode potential shift. It can be used to further analyze and compare mitochondrial membrane transporters produced under similar conditions.
The authors have nothing to disclose.
This work was supported by the Austrian Research Fund (P31559-B20 to E.E.P.). The authors thank Sarah Bardakji for the excellent technical assistance in the production and reconstitution of mouse UCP1 and UCP3 into proteoliposomes.
Microloader tips | Eppendorf | 5242956.003 | Microcapillary pipette tip |
Ethanol 99% | AustrAlco Österr. Agrar-Alkohol Handelsges.m.b.H | AAAH-5020-07025-230317 | |
Kaliumchlorid | Carl Roth GmbH + Co. Kg | 6781.3 | |
DC supply | Voltcraft | V10/CPG 1940 -01 | |
Agarose Standard | Carl Roth GmbH + Co. Kg | 3810.2 | |
Patch Clamp Amplifier | Heka | ||
Sample tube | Carl Roth GmbH + Co. Kg | 5863.1 | |
Na2SO4 | Carl Roth GmbH + Co. Kg | 8560.3 | |
MES | Carl Roth GmbH + Co. Kg | 4256.2 | |
TRIS | Carl Roth GmbH + Co. Kg | AE15.2 | |
EGTA | Carl Roth GmbH + Co. Kg | 3054.1 | |
Hexane | Sigma-Aldrich | 296090-100ML | |
Hexadecane | Sigma-Aldrich | 296317-100ML | |
Heating wire | Voltcraft | USPS-2250 |